PPCB

← Markets

PPCBPropanc Biopharma, Inc.

Discussion

Nothing said here yet.

to join the conversation.

—

Thu, Aug 27
9:29 AMinvestorshub.advfn.comPropanc Biopharma Reports PRP Preclinical Pancreatic Cancer Data Showing Over 90% Tumor Growth Inhibition
7:30 AMstocktitan.netPropanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit
Tue, Aug 18
7:30 AMYahooPropanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP
Wed, Aug 12
7:30 AMYahooPropanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
Thu, Aug 6
7:30 AMYahooPropanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models
Wed, Aug 5
7:30 AMYahooPropanc Biopharma Completes First Tranche of $5.0 Million Share Repurchase Program
Tue, Jul 21
7:30 AMYahooPropanc Biopharma Publishes Evaluation of Recombinant Trypsinogen & Chymotrypsinogen in Peer Reviewed Journal
Tue, Jul 7
7:30 AMYahooPropanc Biopharma Signs MOU with Avance Clinical Pty Ltd
Thu, Jul 2
7:30 AMYahooPropanc Biopharma Initiates $5.0 Million Share Repurchase Program
Tue, Jun 16
7:45 AMYahooPropanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study
Thu, Jun 11
11:37 AMstocktwits.comPPCB Stock Surges Over 200% Just Days After Implementing Reverse Share Split – What’s Driving Today’s Smashing Rally?
7:30 AMYahooPropanc Biopharma Authorizes $5.0 Million Share Repurchase Program